Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of a natural health product among participants with elevated LDL cholesterol and triglyceride levels.


Clinical Trial Description

Cardiovascular Disease [CVD] is one of the primary causes of illness, disability and death in Canada and in the United States. Hypercholesterolemia and hypertriglyceridemia are significant risk factors for the development of cardiovascular disease.

The investigational product used in this trial, has been specially formulated to help reduce elevated triglycerides and LDL cholesterol levels, and may provide a natural alternative in the prevention of CVD.

This study is a prospective, 12 week study, where participants will be randomized to receive the treatment, placebo, or a comparator product for a period of 12 weeks. Blood lipids will be analysed at baseline, week 6 and week 12. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01028274
Study type Interventional
Source Nordic Pharma, USA
Contact
Status Completed
Phase Phase 1/Phase 2
Start date September 2009
Completion date August 2010

See also
  Status Clinical Trial Phase
Completed NCT03549260 - Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction Phase 2
Completed NCT00233649 - DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines Phase 4
Recruiting NCT05765370 - LDL Cholesterol TARGETs in OLDer Patients (Ageā‰„75 Years) With ASCVD (TARGET OLD) N/A
Recruiting NCT05778656 - Cardiovascular Risk Prevention With a Mediterranean Dietary Pattern Reduced in Saturated Fat N/A
Completed NCT01859455 - Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins Phase 1
Active, not recruiting NCT02068248 - Effect of Viscous Soluble Fibers on Serum Cholesterol Levels N/A
Completed NCT03346486 - Dietary Intervention With Brain-friendly Diet N/A
Completed NCT02330406 - Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial Phase 4
Completed NCT00522158 - Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition Phase 4